| Literature DB >> 31408441 |
Max Rieckmann1, Murilo Delgobo2,3, Chiara Gaal2,3, Lotte Büchner2,3, Philipp Steinau1, Dan Reshef4, Cristina Gil-Cruz5, Ellis N Ter Horst6,7,8,9, Malte Kircher10, Theresa Reiter2,3, Katrin G Heinze11, Hans Wm Niessen7,8, Paul Aj Krijnen7,8, Anja M van der Laan6, Jan J Piek6,8, Charlotte Koch1, Hans-Jürgen Wester12, Constantin Lapa10, Wolfgang R Bauer2,3, Burkhard Ludewig5, Nir Friedman4, Stefan Frantz1,2,3, Ulrich Hofmann1,2,3, Gustavo Campos Ramos1,2,3.
Abstract
T cell autoreactivity is a hallmark of autoimmune diseases but can also benefit self-maintenance and foster tissue repair. Herein, we investigated whether heart-specific T cells exert salutary or detrimental effects in the context of myocardial infarction (MI), the leading cause of death worldwide. After screening more than 150 class-II-restricted epitopes, we found that myosin heavy chain alpha (MYHCA) was a dominant cardiac antigen triggering post-MI CD4+ T cell activation in mice. Transferred MYHCA614-629-specific CD4+ T (TCR-M) cells selectively accumulated in the myocardium and mediastinal lymph nodes (med-LN) of infarcted mice, acquired a Treg phenotype with a distinct pro-healing gene expression profile, and mediated cardioprotection. Myocardial Treg cells were also detected in autopsies from patients who suffered a MI. Noninvasive PET/CT imaging using a CXCR4 radioligand revealed enlarged med-LNs with increased cellularity in MI-patients. Notably, the med-LN alterations observed in MI patients correlated with the infarct size and cardiac function. Taken together, the results obtained in our study provide evidence showing that MI-context induces pro-healing T cell autoimmunity in mice and confirms the existence of an analogous heart/med-LN/T cell axis in MI patients.Entities:
Keywords: Adaptive immunity; Cardiology; Heart failure; Immunology; T cells
Mesh:
Substances:
Year: 2019 PMID: 31408441 PMCID: PMC6819128 DOI: 10.1172/JCI123859
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808